Audio: D'Arcy v Myriad: The High Court rules on gene patenting
7 October 2015
In brief: The High Court unanimously overturned the Full Federal Court's decision in D'Arcy v Myriad Genetics that isolated genetic material was patentable.
Allens Partner Dr Trevor Davies (view CV) discusses why the High Court overturned the decision and what it means for the biotech industry.
- Dr Trevor DaviesPartner, Allens Patent & Trade Mark Attorneys,
Ph: +61 2 9230 4007
You can leave a comment on this publication below. Please note, we are not able to provide specific legal advice in this forum. If you would like advice relating to this topic, contact one of the authors directly. Please do not include links to websites or your comment may not be published.